He swore on his life that I had nothing to worry about.
‘How could he do this to me?’ I sobbed intoOnly minutes earlier, Google had confirmed that the pills concealed in my boyfriend’s suitcase were antiretroviral medicines, or ARVs. Medication to treat HIV.I didn’t know it at the time, but when you’re taking your HIV treatment properly you can become undetectable, which means you can’t pass it on to anyone else.
Dave was tall, handsome and I liked him a lot. After two weeks of chatting on Grindr, we started arranging online ‘dates’ – and Dave asked me to be his boyfriend. Though we’d never met, it just felt right., where I’m from, has anti-gay laws and my parents are religiously homophobic. I’d known I liked boys since I was 10, and never had a problem accepting my sexuality.
I was an unemployed student, so it felt good having someone like Dave – older and more experienced – finally watching out for me.We talked every day and after months,lifted, we decided to meet. He lived a long drive from me, so we agreed to travel to a different state to spend a week together. The decision was taken out of my hands though, as the receptionist had already informed him I was coming, so he opened the door, pulled me inside and kissed my lips.Seeing my hand shaking, he smiled. ‘Relax,’ he whispered.If only I’d known how short-lived that happiness would be…
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Study uncovers relationship between HIV-1 infection and neurodegenerationNorthwestern Medicine scientists have discovered how HIV hijacks intracellular processes to proliferate and contribute to neurodegeneration, according to a new study published in Nature Communications.
Lire la suite »
Novel treatment based on gene editing safely and effectively removes HIV-like virus from genomes of non-human primatesA single injection of a novel CRISPR gene-editing treatment safely and efficiently removes SIV—a virus related to the AIDS-causing agent HIV—from the genomes of non-human primates, scientists at the Lewis Katz School of Medicine at Temple University now report. The groundbreaking work complements previous experiments as the basis for the first-ever clinical trial of an HIV gene-editing technology in human patients, which was authorized by the Food and Drug Administration (FDA) in 2022.
Lire la suite »
- medical research advances and health newsMedical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and conditions, medications and more.
Lire la suite »
- medical research advances and health newsMedical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and conditions, medications and more.
Lire la suite »
- medical research advances and health newsMedical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and conditions, medications and more.
Lire la suite »
- medical research advances and health newsMedical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and conditions, medications and more.
Lire la suite »